The macrophage-mediated effects of the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuate tactile allodynia in the early phase of neuropathic pain development.

Source:http://linkedlifedata.com/resource/pubmed/id/21490083

Download in:

View as

General Info

PMID
21490083